Predicting for activity of second-line trastuzumab-based therapy in her2-positive advanced breast cancer.

BMC Cancer · 2009 · PMC2770076 · PMID 19835621

Europe PMC DOI

hedged sentence

0.0800

closest p · 1.6× alpha

0.0800

boldest claim

The sentences

near significancep < 0.08so close (0.05 < p ≤ 0.1)

Variables exhibiting significance (p < 0.05) or near significance (p < 0.08) at univariate analysis were included into the Cox regression models.

also in 505 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.